We are live on
!
Find out more
SM
SG3 Management Portfolio holdings
AUM
$6.45K
1-Year Est. Return
61.81%
This Fund
S&P 500
This Quarter
Est. Return
+9.09%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
–
AUM
$4B
AUM Growth
-$1.25B
(-24%)
Cap. Flow
-$1.28B
Cap. Flow
% of AUM
-32.02%
Top 10 Holdings %
Top 10 Hldgs %
20.82%
Holding
1,612
New
626
Increased
195
Reduced
208
Closed
487
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$10.2M |
| 2 |
PARA
Paramount Global Class B
PARA
|
+$6.08M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$5.95M |
| 4 |
Biogen
BIIB
|
+$5.94M |
| 5 |
Aon
AON
|
+$5.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$294M |
| 2 |
Lennar Class A
LEN
|
+$76.3M |
| 3 |
RH
RH
|
+$25.1M |
| 4 |
ARK Genomic Revolution ETF
ARKG
|
+$22.5M |
| 5 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$22.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 1.79% |
| 2 | Communication Services | 1.57% |
| 3 | Technology | 1.13% |
| 4 | Consumer Discretionary | 1.05% |
| 5 | Financials | 0.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LOTZ
351
CALL
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
| $2.44M | 0.06% |
+342,200
| New | +$3.32M |
|
|
SPR
352
CALL
DELISTED
Spirit AeroSystems
SPR
| $2.43M | 0.06% |
+50,000
| New | +$2.14M |
|
353
CALL
Qfin Holdings
QFIN
$1.69B
| $2.43M | 0.06% |
+93,500
| New | +$2.08M |
|
354
Neurocrine Biosciences
NBIX
$18.7B
| $2.43M | 0.06% |
+25,000
| New | +$2.62M |
|
|
SCPL
355
PUT
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
| $2.43M | 0.06% |
+150,000
| New | +$2.58M |
|
356
PUT
Cigna
CI
$76.1B
| $2.42M | 0.06% |
10,000
-13,700
| -58% | -$3.05M |
|
357
Norfolk Southern
NSC
$75B
| $2.42M | 0.06% |
+9,000
| New | +$2.28M |
|
358
PUT
Starbucks
SBUX
$121B
| $2.42M | 0.06% |
+22,100
| New | +$2.32M |
|
|
MAG
359
CALL
DELISTED
MAG Silver
MAG
| $2.4M | 0.06% |
160,000
| – | – |
|
360
CALL
CEL-SCI Corp
CVM
$21.3M
| $2.4M | 0.06% |
+5,260
| New | +$2.87M |
|
361
PUT
Dave & Buster's
PLAY
$377M
| $2.4M | 0.06% |
+50,000
| New | +$1.95M |
|
362
PUT
West Pharmaceutical
WST
$23.9B
| $2.4M | 0.06% |
8,500
| – | – |
|
363
PUT
American Tower
AMT
$81.3B
| $2.39M | 0.06% |
+10,000
| New | +$2.23M |
|
364
State Street SPDR S&P Retail ETF
XRT
$453M
| $2.39M | 0.06% |
+26,742
| New | +$2.16M |
|
365
Twilio
TWLO
$29B
| $2.38M | 0.06% |
7,000
+6,000
| +600% | +$2.25M |
|
|
FISV
366
PUT
Fiserv Inc
FISV
$28.8B
| $2.38M | 0.06% |
+20,000
| New | +$2.3M |
|
367
TSMC
TSM
$2.09T
| $2.37M | 0.06% |
20,000
+18,600
| +1,329% | +$2.3M |
|
368
PUT
Cencora
COR
$60.7B
| $2.36M | 0.06% |
+20,000
| New | +$2.16M |
|
369
CALL
Microsoft
MSFT
$3.35T
| $2.36M | 0.06% |
10,000
-23,000
| -70% | -$5.34M |
|
370
PUT
Acadia Pharmaceuticals
ACAD
$4.55B
| $2.35M | 0.06% |
+91,100
| New | +$4.01M |
|
371
CALL
Coca-Cola Europacific Partners
CCEP
$49.3B
| $2.35M | 0.06% |
45,000
+20,000
| +80% | +$1.02M |
|
372
PUT
DXC Technology
DXC
$1.82B
| $2.35M | 0.06% |
+75,000
| New | +$2.06M |
|
373
PUT
DexCom
DXCM
$28.8B
| $2.34M | 0.06% |
+26,000
| New | +$2.44M |
|
374
CALL
KraneShares CSI China Internet ETF
KWEB
$5.55B
| $2.29M | 0.06% |
+30,000
| New | +$2.63M |
|
375
CALL
Amplify Alternative Harvest ETF
MJ
$101M
| $2.29M | 0.06% |
8,333
+2,450
| +42% | +$647K |
|
Similar funds
EAM
CAM
CCM
GPCM
MAM
BGCI
TPL
RC
SG3 Management's Q1 2021 Portfolio in Review
As of Q1 2021, SG3 Management held 1,612 positions worth $4B, down 24% from $5.25B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
SG3 Management withdrew a net $1.28B in Q1 2021, closing 487 positions and reducing 208 holdings. Its most notable exit was Amazon, an estimated $294M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 1.8% of assets, up from 0.67% a quarter earlier, followed by Communication Services and Technology.
Against the trend, SG3 Management opened a new position in Albemarle worth $4.16M.
- SG3 Management's largest Q1 2021 buy was Albemarle: 28,500 shares worth $4.16M.
- SG3 Management added most to Jazz Pharmaceuticals in Q1 2021, an estimated $10.2M increase.
- SG3 Management's biggest Q1 2021 reduction was RH, cutting an estimated $25.1M.
- SG3 Management fully exited Amazon in Q1 2021, selling an estimated $294M.
- SG3 Management's ten largest holdings make up 21% of its $4B portfolio in Q1 2021.
- SG3 Management opened 626 new positions and closed 487 in Q1 2021.
- SG3 Management's portfolio value fell 24% quarter-over-quarter to $4B.
Based on SG3 Management's 13F filing for Q1 2021, filed 17 May 2021.